Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 4
1990 4
1991 7
1992 1
1993 3
1994 3
1995 3
1996 2
1997 4
1998 5
1999 1
2000 1
2002 1
2004 1
2005 1
2006 2
2007 4
2009 3
2011 1
2012 2
2014 2
2016 2
2017 1
2018 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
The activities of drug inactive ingredients on biological targets.
Pottel J, Armstrong D, Zou L, Fekete A, Huang XP, Torosyan H, Bednarczyk D, Whitebread S, Bhhatarai B, Liang G, Jin H, Ghaemi SN, Slocum S, Lukacs KV, Irwin JJ, Berg EL, Giacomini KM, Roth BL, Shoichet BK, Urban L. Pottel J, et al. Among authors: whitebread s. Science. 2020 Jul 24;369(6502):403-413. doi: 10.1126/science.aaz9906. Science. 2020. PMID: 32703874 Free PMC article.
In vitro safety pharmacology profiling: what else beyond hERG?
Hamon J, Whitebread S, Techer-Etienne V, Le Coq H, Azzaoui K, Urban L. Hamon J, et al. Among authors: whitebread s. Future Med Chem. 2009 Jul;1(4):645-65. doi: 10.4155/fmc.09.51. Future Med Chem. 2009. PMID: 21426031 Review.
Angiotensin II receptor subtypes and cardiac function.
de Gasparo M, Rogg H, Brink M, Wang L, Whitebread S, Bullock G, Erne P. de Gasparo M, et al. Among authors: whitebread s. Eur Heart J. 1994 Dec;15 Suppl D:98-103. doi: 10.1093/eurheartj/15.suppl_d.98. Eur Heart J. 1994. PMID: 7713122 Review.
Implications of Dynamic Occupancy, Binding Kinetics, and Channel Gating Kinetics for hERG Blocker Safety Assessment and Mitigation.
Pearlstein RA, MacCannell KA, Erdemli G, Yeola S, Helmlinger G, Hu QY, Farid R, Egan W, Whitebread S, Springer C, Beck J, Wang HR, Maciejewski M, Urban L, Duca JS. Pearlstein RA, et al. Among authors: whitebread s. Curr Top Med Chem. 2016;16(16):1792-818. doi: 10.2174/1568026616666160315142156. Curr Top Med Chem. 2016. PMID: 26975508 Review.
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
Reck F, Bermingham A, Blais J, Capka V, Cariaga T, Casarez A, Colvin R, Dean CR, Fekete A, Gong W, Growcott E, Guo H, Jones AK, Li C, Li F, Lin X, Lindvall M, Lopez S, McKenney D, Metzger L, Moser HE, Prathapam R, Rasper D, Rudewicz P, Sethuraman V, Shen X, Shaul J, Simmons RL, Tashiro K, Tang D, Tjandra M, Turner N, Uehara T, Vitt C, Whitebread S, Yifru A, Zang X, Zhu Q. Reck F, et al. Among authors: whitebread s. Bioorg Med Chem Lett. 2018 Feb 15;28(4):748-755. doi: 10.1016/j.bmcl.2018.01.006. Epub 2018 Jan 4. Bioorg Med Chem Lett. 2018. PMID: 29336873
61 results